Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats.
about
Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease modelsQuality Assessment of Panax notoginseng from Different Regions through the Analysis of Marker Chemicals, Biological Potency and Ecological FactorsRational design of a β-glycosidase with high regiospecificity for triterpenoid tailoringA Role of Ginseng and Its Constituents in the Treatment of Central Nervous System DisordersGinseng compounds: an update on their molecular mechanisms and medical applicationsPharmacology of ginsenosides: a literature reviewA system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatmentEffect of compatible herbs on the pharmacokinetics of effective components of Panax notoginseng in Fufang Xueshuantong Capsule.Comparative analysis of the expression level of recombinant ginsenoside-transforming β-glucosidase in GRAS hosts and mass production of the ginsenoside Rh2-MixIdentification and characterization of a novel Terrabacter ginsenosidimutans sp. nov. beta-glucosidase that transforms ginsenoside Rb1 into the rare gypenosides XVII and LXXV.An LC-MS method for simultaneous determination of nine ginsenosides in rat plasma and its application in pharmacokinetic study.Simultaneous determination of three major bioactive saponins of Panax notoginseng using liquid chromatography-tandem mass spectrometry and a pharmacokinetic study.Isolation and analysis of ginseng: advances and challenges.Efficacy and Safety of Panax notoginseng Saponin Therapy for Acute Intracerebral Hemorrhage, Meta-Analysis, and Mini Review of Potential Mechanisms of Action.The effectiveness of borneol on pharmacokinetics changes of four ginsenosides in Shexiang Baoxin Pill in vivo.Pharmacokinetics study of bio-adhesive tablet of Panax notoginseng saponinsSimultaneous determination of seven ginsenosides in rat plasma by high-performance liquid chromatography coupled to time-of-flight mass spectrometry: application to pharmacokinetics of Shenfu injection.Tissue distribution and excretion study of neopanaxadiol in rats by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry.Development of a sensitive LC-MS/MS method for simultaneous quantification of eleven constituents in rat serum and its application to a pharmacokinetic study of a Chinese medicine Shengmai injection.Ginseng derivative ocotillol enhances neuronal activity through increased glutamate release: a possible mechanism underlying increased spontaneous locomotor activity of mice.Effect of Fermented Red Ginseng Extract Enriched in Ginsenoside Rg3 on the Differentiation and Mineralization of Preosteoblastic MC3T3-E1 Cells.Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis.The efficacy and safety of Chinese herbal medicines.Metabolite identification of seven active components of Huan-Nao-Yi-Cong-Fang in rat plasma using high-performance liquid chromatography combined with hybrid ion trap/time-of-flight mass spectrometry.Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjectsLow-dose ginseng (Panax quinquefolium) modulates the course and magnitude of the antibody response to vaccination against equid herpesvirus I in horsesAnalysis of Panax notoginseng metabolites in rat bile by liquid chromatography-quadrupole time-of-flight mass spectrometry with microdialysis sampling.Simultaneous determination of ginsenoside Rg1 , Re and notoginsenoside R1 in human plasma by LC-MS/MS and its application in a pharmacokinetic study in Chinese volunteers.Saponins from the traditional medicinal plant Momordica charantia stimulate insulin secretion in vitro.Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora.Anti-fatigue effects of Panax notoginseng in simulation plateau-condition micePharmacological activity of sanchi ginseng (Panax notoginseng).Effects of Borneol on Pharmacokinetics and Tissue Distribution of Notoginsenoside R1 and Ginsenosides Rg1 and Re in Panax notoginseng in Rabbits.Enzymatic formation of compound-K from ginsenoside Rb1 by enzyme preparation from cultured mycelia of Armillaria mellea.Bioanalysis in drug discovery and development.The antitumor activity study of ginsenosides and metabolites in lung cancer cell.The effects and mechanism of ginsenoside Rg1 on myocardial remodeling in an animal model of chronic thromboembolic pulmonary hypertension.Microbial conversion of major ginsenosides in ginseng total saponins by Platycodon grandiflorum endophytes.Simultaneous quantification of ginsenoside Rg1 and its metabolites by HPLC-MS/MS: Rg1 excretion in rat bile, urine and feces.Subacute oral toxicity study of korean red ginseng extract in sprague-dawley rats.
P2860
Q26775886-9F2C27FE-982D-45F9-BEDE-E4521353223FQ27320552-6A1B0B48-C847-4235-A7A5-98D15B16C025Q27698045-67B242D3-06FF-423E-AA5B-F2EC64BC9B0BQ28072689-6A3450C7-6D04-4C80-9AD5-8CE03F22C4D4Q28251905-D4B53B30-2105-44B6-8321-818F35256563Q28284834-E6CE3B5D-6C21-4BBF-9EB9-2FDFA6D8889AQ28483412-47B98EF5-75CC-4D7A-AEAF-95F64FAA8097Q33571413-4F4726C0-AADE-45EF-B0E6-3D43E54DC9D2Q33579703-A6E834D8-33CE-4E1B-8456-97E26D772BAFQ33630182-D1A2B3CC-8F20-4B6C-9B5B-6EF936D7E8DCQ33682444-1192ECE6-6355-47D1-80C1-EE7327CD3668Q33766042-0B372C14-4604-4D46-9CE6-53125B670309Q34667126-C5667AF5-DF7C-4422-B365-9C992D8CCA3CQ34881598-9E27DA61-E20B-466D-8A9E-C6B4948F9B0DQ35016625-DA2E62DA-FF6E-4EE1-8B9F-6B22336F615DQ35063665-DF6DBD8E-CFF6-4C90-99C8-89BA7C8064F2Q35189311-A14C3146-B54A-413C-A24D-4A7B2F8E76DCQ35194256-1B81023B-001F-47E2-8ED6-3969DFA8F4E7Q35209863-62DFF0A7-49AA-4929-9BA7-0E7761825037Q35353349-16E3EC98-6816-4525-8D77-BF7D72B889A4Q35540865-3FABB3CA-EB20-40F5-A6CA-028A6ABD39C1Q35544526-9F68994D-A9FD-4E28-8536-1121E6EF855DQ35646077-CC484E6A-CBF4-4637-990A-AEACCD1A7260Q35681912-4AB9F5FB-D263-473B-AE56-896E3397FF76Q35826093-A38199AD-2055-427C-A8F8-8B3FC74CAA99Q35856656-FB308C4E-783E-43E3-A994-5521ED6C2F56Q35911467-60ED3A3D-A426-42A1-BA44-7340D5211654Q36027918-7A0DB793-DC7D-4BE0-B800-E4D2BFFB57ABQ36075647-08378C78-7297-4F23-AD0B-2CDBA1295875Q36105337-4D31588E-DD44-4F26-B7E4-BE01A2F157A7Q36303918-27BFA2A8-F909-4E39-9B68-A731429B2D50Q36548823-917073F4-A938-42EE-9D7A-A3A9CBA0EEEDQ36765621-1B4CF24F-AFBE-40A6-B923-5113A528D871Q36835741-341BD351-9228-4A58-9A9F-F0BADA0670B1Q36855961-F2CBC9CD-000A-4FEC-A738-3EC28DC50EC3Q36879558-D1E118A7-FA46-4B9A-8E31-4B4BEA1EDDE4Q36926549-4D0C1199-2C13-496D-BB83-27331B0CB951Q37314423-6E1AD233-9D7F-4765-88E2-8FE62A2F1650Q37352220-CF491613-B7FF-46C8-89EC-6A4088B81015Q37605718-8CF51344-FDD2-4067-9A0F-9BC2E3BC7133
P2860
Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Pharmacokinetics and bioavaila ...... rom Panax notoginseng in rats.
@en
Pharmacokinetics and bioavaila ...... rom Panax notoginseng in rats.
@nl
type
label
Pharmacokinetics and bioavaila ...... rom Panax notoginseng in rats.
@en
Pharmacokinetics and bioavaila ...... rom Panax notoginseng in rats.
@nl
prefLabel
Pharmacokinetics and bioavaila ...... rom Panax notoginseng in rats.
@en
Pharmacokinetics and bioavaila ...... rom Panax notoginseng in rats.
@nl
P2093
P1476
Pharmacokinetics and bioavaila ...... rom Panax notoginseng in rats.
@en
P2093
Dao Feng Chen
Qing Fang Xu
Xiao Ling Fang
P304
P356
10.1016/S0378-8741(02)00317-3
P577
2003-02-01T00:00:00Z